GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $602,000 | +88.1% | 8,846 | +19.6% | 0.00% | +200.0% |
| Q4 2020 | $320,000 | -80.9% | 7,394 | -75.6% | 0.00% | -87.5% |
| Q3 2020 | $1,672,000 | -83.9% | 30,319 | -81.6% | 0.01% | -84.0% |
| Q2 2020 | $10,402,000 | +1116.6% | 164,767 | +884.9% | 0.05% | +900.0% |
| Q1 2020 | $855,000 | -33.0% | 16,729 | +4.1% | 0.01% | -16.7% |
| Q4 2019 | $1,277,000 | +63.9% | 16,065 | 0.0% | 0.01% | +50.0% |
| Q3 2019 | $779,000 | -7.8% | 16,065 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $845,000 | -36.3% | 16,065 | -35.9% | 0.01% | -28.6% |
| Q1 2019 | $1,326,000 | +28.5% | 25,055 | -0.4% | 0.01% | +16.7% |
| Q4 2018 | $1,032,000 | -18.4% | 25,145 | -24.5% | 0.01% | -14.3% |
| Q3 2018 | $1,265,000 | -61.3% | 33,300 | -53.9% | 0.01% | -61.1% |
| Q2 2018 | $3,268,000 | +869.7% | 72,300 | +935.8% | 0.02% | +800.0% |
| Q1 2018 | $337,000 | – | 6,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |